**Author details**

I. Andia1\*, E. Rubio-Azpeitia1 , J.I. Martin1 and M. Abate2

\*Address all correspondence to: iandia2010@hotmail.com

1 BioCruces Health Research Institute/Cruces University Hospital, Barakaldo, Spain

2 Department of Medicine and Science of Aging, University G. d'Annunzio, Chieti-Pescara, Italy

## **References**


[3] Närhi MO, Nordström K. Regulation of cell based therapeutic products intended for human applications in the EU. Reg Med 2014;9(3):327-351

Refractory ocular GVDH\*

Non-healing ulcers\*\*\* Diabetic ulcer Neurogenic Arterial traumatic Pressure ulcers Vascular ulcers Treatment of striae distensae\* Androgenetic alopecia\* Peripheral neuropathy\*

Severe deep sternal wound infection\*\*

Chondropathy and Osteoarthritis\*\*\*

Recalcitrant hindfoot and ankle disease\*\*

and M. Abate2

2 Department of Medicine and Science of Aging, University G. d'Annunzio, Chieti-Pescara,

[1] Oerlemans AJM, van Hoeck MEC, van Leeuwen E, Dekkers WJM. Hype and expecta‐

[2] Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials. Reg Med

1 BioCruces Health Research Institute/Cruces University Hospital, Barakaldo, Spain

Per-cutaneous non-unions\*

, J.I. Martin1

tions in tissue engineering. Reg Med 2014;9(1):113-122

\*Address all correspondence to: iandia2010@hotmail.com

Tendinopathies\*\*\* Muscle injuries\*\* Ligament injuries\* Fasciitis plantar\*\*

**Cardiology** Complications of sternotomy\*\*

**Dermatology**

24 Biotechnology

**Sports Medicine and Orthopedics**

**Author details**

Italy

**References**

I. Andia1\*, E. Rubio-Azpeitia1

2014;9(1):27-39

**Table 4.** Conservative clinical applications of PRP therapies


dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation path‐ way. Genes Dev. 2008 Jul 1;22(13):1747-52.


[29] Farrag TY, Lehar M, Verhaegen P, Carson KA, Byrne PJ. Effect of platelet rich plasma and fibrin sealant on facial nerve regeneration in a rat model. Laryngoscope. 2007 Jan;117(1):157-65.

dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation path‐

[17] Bir SC, Esaki J, Marui A, Sakaguchi H, Kevil CG, Ikeda T, Komeda M, Tabata Y, Sa‐ kata R. Therapeutic treatment with sustained-release platelet-rich plasma restores blood perfusion by augmenting ischemia-induced angiogenesis and arteriogenesis in

[18] Richardson TP1, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual

[19] Dellavalle A, Maroli G, Covarello D, Azzoni E, Innocenzi A, Perani L, Antonini S, Sambasivan R, Brunelli S, Tajbakhsh S, Cossu G. Pericytes resident in postnatal skele‐ tal muscle differentiate into muscle fibres and generate satellite cells. Nat Commun.

[20] Cappellari O, Cossu G. Pericytes in development and pathology of skeletal muscle.

[21] Andia I, Abate M. Platelet rich plasma injections for tendinopathy and osteoarthritis.

[22] Lev EI, Estrov Z, Aboulfatova K, Harris D, Granada JF, Alviar C, Kleiman NS, Dong JF. Potential role of activated platelets in homing of human endothelial progenitor

[23] Lee JK, Lee S, Han SA, Seong SC, Lee MC. The effect of platelet-rich plasma on the differentiation of synovium-derived mesenchymal stem cells. J Orthop Res.

[24] Chen L, Dong SW, Tao X, Liu JP, Tang KL, Xu JZ. Autologous platelet-rich clot relea‐ sate stimulates proliferation and inhibits differentiation of adult rat tendon stem cells

[25] Li H, Usas A, Poddar M, Chen CW, Thompson S, Ahani B, Cummins J, Lavasani M, Huard J. Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness. PLoS One. 2013 Jun 7;8(6):e64923.

[26] Rubio-Azpeitia E, Andia I. Partnership between platelet-rich plasma and mesenchy‐ mal stem cells: in vitro experience. Muscles Ligaments Tendons J. 2014 May 8;4(1):

[27] Madduri S, Gander B. Schwann cell delivery of neurotrophic factors for peripheral

[28] Emel E, Ergün SS, Kotan D, Gürsoy EB, Parman Y, Zengin A, Nurten A. Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a

cells to subendothelial matrix. Thromb Haemost. 2006 Oct;96(4):498-504

towards nontenocyte lineages. J Int Med Res. 2012;40(4):1399-409

nerve regeneration. J Peripher Nerv Syst. 2010;15(2):93-103.

rat model. J Neurosurg. 2011 Feb;114(2):522-8.

growth factor delivery. Nat Biotechnol. 2001 Nov;19(11):1029-34.

way. Genes Dev. 2008 Jul 1;22(13):1747-52.

diabetic mice. J Vasc Res. 2011;48(3):195-205.

2011 Oct 11;2:499.

26 Biotechnology

2014;32(10):1317-25

52-62.

Circ Res. 2013 Jul 19;113(3):341-7.

Int J Clin Rheumatol 2012; 7(4): 397-412


construction? Platelet-rich plasma in secondary alveoloplasty. Med Oral Patol Oral Cir Bucal. 2010 Jul 1;15(4):e619-23

[53] Marukawa E, Oshina H, Iino G, Morita K, Omura K. Reduction of bone resorption by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar cleft. J Craniomaxillofac Surg. 2011;39(4):278-83

[41] Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activat‐ ed platelet supernatant, topical versus placebo. Diabetes Care. 1992;15(11):1598-604

[42] de Leon JM, Driver VR, Fylling CP, Carter MJ, Anderson C, Wilson J, Dougherty RM, Fuston D, Trigilia D, Valenski V, Rappl LM. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma

[43] Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty. 2011;11:e38. Epub 2011 Sep 15.

[44] Kanemaru H, Kajihara I, Yamanaka K, Igata T, Makino T, Masuguchi S, Fukushima S, Jinnin M, Ihn H. Platelet-rich plasma therapy is effective for the treatment of re‐ fractory skin ulcers in patients with systemic sclerosis. Mod Rheumatol. 2014 Jun

[45] Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Expósito JA, Bolíbar I, Rodríguez L, Garcia J. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Da‐

[46] Carter MJ, Fylling CP, Li WW, de Leon J, Driver VR, Serena TE, Wilson J. Analysis of run-in and treatment data in a wound outcomes registry: clinical impact of topical platelet-rich plasma gel on healing trajectory. Int Wound J. 2011 Dec;8(6):638-50.

[47] Dougherty EJ. An evidence-based model comparing the cost-effectiveness of plateletrich plasma gel to alternative therapies for patients with nonhealing diabetic foot ul‐

[48] Del Fabbro M, Bortolin M, Taschieri S. Is autologous platelet concentrate beneficial for post-extraction socket healing? A systematic review. Int J Oral Maxillofac Surg.

[49] Khairy NM, Shendy EE, Askar NA, El-Rouby DH. Effect of platelet rich plasma on bone regeneration in maxillary sinus augmentation (randomized clinical trial). Int J

[50] González-Sánchez JG, Jiménez-Barragán K. Closure of recurrent cleft palate fistulas with plasma rich in growth factors. Acta Otorrinolaringol Esp. 2011 Nov-Dec;62(6):

[51] Lee C, Nishihara K, Okawachi T, Iwashita Y, Majima HJ, Nakamura N. A quantita‐ tive radiological assessment of outcomes of autogenous bone graft combined with platelet-rich plasma in the alveolar cleft. Int J Oral Maxillofac Surg. 2009 Feb;38(2):

[52] Luaces-Rey R, Arenaz-Búa J, Lopez-Cedrún-Cembranos JL, Herrero-Patiño S, Siron‐ valle-Soliva S, Iglesias-Candal E, Pombo-Castro M. Is PRP useful in alveolar cleft re‐

gel. Adv Skin Wound Care. 2011 Aug;24(8):357-68

cers. Adv Skin Wound Care. 2008 Dec;21(12):568-75.

Oral Maxillofac Surg. 2013 Feb;42(2):249-55

16:1-2.

28 Biotechnology

tabase Syst Rev. 2012

2011 Sep;40(9):891-900

448-53.

117-25


telet-rich plasma and cancellous bone substitute: an osteoinductive and osteoconduc‐ tive effect. Global Spine J. 2014 Aug;4(3):137-42.


[78] Avila MY. Restoration of human lacrimal function following platelet-rich plasma in‐ jection. Cornea. 2014 Jan;33(1):18-21

telet-rich plasma and cancellous bone substitute: an osteoinductive and osteoconduc‐

[67] Sys J, Weyler J, Van Der Zijden T, Parizel P, Michielsen J.Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion. Eur Spine J. 2011;20(10):1650-7.

[68] Wang SZ, Rui YF, Tan Q, Wang C. Enhancing intervertebral disc repair and regener‐ ation through biology: platelet-rich plasma as an alternative strategy. Arthritis Res

[69] Chang KV, Hung CY, Aliwarga F, Wang TG, Han DS, Chen WS.Comparative effec‐ tiveness of platelet-rich plasma injections for treating knee joint cartilage degenera‐ tive pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014

[70] Khoshbin A(1), Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Har‐ risD, Gandhi R, Takhar K, Lum G, Chahal J. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantita‐

[71] [71] Sánchez M1, Guadilla J, Fiz N, Andia I. Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford). 2012

[72] Chahal J, Van Thiel GS, Mall N, Heard W, Bach BR, Cole BJ, Nicholson GP, Verma NN, Whelan DB, Romeo AA.The role of platelet-rich plasma in arthroscopic rotator cuff repair: a systematic review with quantitative synthesis. Arthroscopy. 2012 Nov;

[73] Ahmad Z, Brooks R, Kang SN, Weaver H, Nunney I, Tytherleigh-Strong G, Rushton N. The effect of platelet-rich plasma on clinical outcomes in lateral epicondylitis. Ar‐

[74] A Hamid MS, Mohamed Ali MR, Yusof A, George J, Lee LP. Platelet-Rich Plasma In‐ jections for the Treatment of Hamstring Injuries: A Randomized Controlled Trial.

[75] Reurink G, Goudswaard GT, Moen MH, Weir A, Verhaar JAN, Maas M, Tol JL. Pla‐ telet rich plasma injections in acute muscle injury. N Engl J Med 2014; 370(26):

[76] Paques M, Chastang C, Mathis A, Sahel J, Massin P, Dosquet C, Korobelnik JF, Le Gargasson JF, Gaudric A. Effect of autologous platelet concentrate in surgery for idi‐ opathic macular hole: results of a multicenter, double-masked, randomized trial. Pla‐

[77] Pan Q1, Angelina A, Zambrano A, Marrone M, Stark WJ, Heflin T, Tang L, Akpek EK. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2013 Aug

telets in Macular Hole Surgery Group. Ophthalmology. 1999;106(5):932-8

tive effect. Global Spine J. 2014 Aug;4(3):137-42.

tive synthesis. Arthroscopy. 2013 Dec;29(12):2037-48

Am J Sports Med. 2014 Jul 29. pii: 0363546514541540

27;8:CD009327. doi: 10.1002/14651858.CD009327.pub2.

Ther. 2013;15(5):220.

30 Biotechnology

Mar;95(3):562-75.

Jan;51(1):144-50.

28(11):1718-27

2546-2547

throscopy. 2013 Nov;29(11):1851-62

